CNC logo CNC
Upturn stock rating
CNC logo

Centene Corp (CNC)

Upturn stock rating
$34.5
Last Close (24-hour delay)
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • 1Y
  • 1M
  • 1W

Upturn Advisory Summary

11/03/2025: CNC (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

19 Analysts rated it

Moderately tracked stock, growing coverage, gaining market and investor attention.

1 Year Target Price $39.29

1 Year Target Price $39.29

Analysts Price Target For last 52 week
$39.29 Target price
52w Low $25.08
Current$34.5
52w High $66.81

Analysis of Past Performance

Type Stock
Historic Profit -19.5%
Avg. Invested days 36
Today’s Advisory PASS
Upturn Star Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulation Last Close 11/03/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 16.96B USD
Price to earnings Ratio -
1Y Target Price 39.29
Price to earnings Ratio -
1Y Target Price 39.29
Volume (30-day avg) 19
Beta 0.48
52 Weeks Range 25.08 - 66.81
Updated Date 11/3/2025
52 Weeks Range 25.08 - 66.81
Updated Date 11/3/2025
Dividends yield (FY) -
Basic EPS (TTM) -10.67

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date 2025-10-29
When Before Market
Estimate -0.18
Actual 0.5

Profitability

Profit Margin -3.16%
Operating Margin (TTM) 0.55%

Management Effectiveness

Return on Assets (TTM) 2.01%
Return on Equity (TTM) -21.86%

Valuation

Trailing PE -
Forward PE 10.37
Enterprise Value 18379517060
Price to Sales(TTM) 0.1
Enterprise Value 18379517060
Price to Sales(TTM) 0.1
Enterprise Value to Revenue 0.1
Enterprise Value to EBITDA 3.91
Shares Outstanding 491518000
Shares Floating 462764197
Shares Outstanding 491518000
Shares Floating 462764197
Percent Insiders 0.46
Percent Institutions 98.73

ai summary icon Upturn AI SWOT

Centene Corp

stock logo

Company Overview

overview logo History and Background

Centene Corporation was founded in 1984 as a managed care organization. Originally focusing on government-sponsored healthcare programs, it has grown to become a major player in the Medicaid, Medicare, and Health Insurance Marketplace spaces. Significant milestones include acquisitions and expansions into new markets and lines of business.

business area logo Core Business Areas

  • Managed Care: Provides managed healthcare services primarily through Medicaid, Medicare, and Marketplace plans. Offers comprehensive healthcare coverage, including medical, behavioral, and pharmacy benefits.
  • Specialty Services: Offers specialty healthcare services such as behavioral health, vision, dental, and pharmacy benefit management (PBM) through Envolve Pharmacy Solutions.
  • International: Operating in some global healthcare markets like Europe offering various healthcare services

leadership logo Leadership and Structure

The leadership team consists of the CEO, CFO, and other key executives. The organizational structure is hierarchical with divisions focused on managed care operations, specialty services, and corporate functions.

Top Products and Market Share

overview logo Key Offerings

  • Medicaid Managed Care: Provides healthcare coverage to low-income individuals and families through state Medicaid programs. Centene is a major player in this market. Competitors: UnitedHealth Group (UNH), Molina Healthcare (MOH), Humana (HUM). In 2023, Medicaid represented approximately 63% of Centene's total health plan premium revenue. Medicaid managed care market share estimated around 14%.
  • Medicare Advantage: Offers Medicare Advantage plans to seniors and other eligible individuals. Competitors: UnitedHealth Group (UNH), Humana (HUM), CVS Health (CVS). Market share is growing, although smaller compared to other established players. Centene's Medicare revenue accounts for 25% of total health plan premium revenue.
  • Health Insurance Marketplace: Offers health insurance plans through the Affordable Care Act (ACA) marketplace. Competitors: UnitedHealth Group (UNH), Cigna (CI), Kaiser Permanente. Rapidly growing segment within Centene's business, accounting for 12% of total health plan premium revenue.

Market Dynamics

industry overview logo Industry Overview

The managed care industry is experiencing growth driven by increasing government spending on healthcare, aging population, and expansion of Medicaid and Medicare programs. Consolidation is also a key trend.

Positioning

Centene is a leading managed care provider focused on government-sponsored healthcare programs. It has a strong presence in the Medicaid market and is expanding its Medicare and Marketplace businesses. Competitive advantages include its expertise in managing complex populations and its scale.

Total Addressable Market (TAM)

The total addressable market for managed care is substantial, estimated to be in the trillions of dollars. Centene is well-positioned to capture a significant portion of this market, especially within the government-sponsored healthcare segment. The Medicaid TAM is estimated to be at $689 billion in 2023. The Medicare Advantage TAM is expected to grow to $590 billion by 2027. ACA Marketplace estimated at over $200 billion annually.

Upturn SWOT Analysis

Strengths

  • Strong presence in Medicaid market
  • Expertise in managing complex populations
  • Scale and geographic diversification
  • Focus on government-sponsored healthcare programs
  • Growing Medicare Advantage business

Weaknesses

  • High reliance on government funding
  • Exposure to regulatory changes
  • Relatively lower margins compared to commercial insurance
  • Integration challenges from acquisitions
  • Debt burden

Opportunities

  • Expansion into new markets and geographies
  • Growth in Medicare Advantage enrollment
  • Increasing demand for value-based care
  • Strategic acquisitions and partnerships
  • Growth in Health Insurance Marketplace

Threats

  • Changes in government healthcare policy
  • Increased competition from other managed care providers
  • Rising healthcare costs
  • Economic downturn affecting Medicaid enrollment
  • Cybersecurity threats

Competitors and Market Share

competitor logo Key Competitors

  • UNH
  • HUM
  • MOH
  • CVS

Competitive Landscape

Centene's advantages include its focus on government-sponsored healthcare and its expertise in managing complex populations. Disadvantages include its reliance on government funding and its relatively lower margins compared to some competitors. Centene is focusing on growing their medicare and marketplace portfolio to be more competitive.

Major Acquisitions

WellCare Health Plans

  • Year: 2020
  • Acquisition Price (USD millions): 17300
  • Strategic Rationale: Expanded Centene's Medicaid and Medicare Advantage businesses and increased its scale and geographic reach.

Growth Trajectory and Initiatives

Historical Growth: Centene has experienced strong growth over the past decade, driven by organic growth, acquisitions, and expansion into new markets.

Future Projections: Analyst estimates project continued revenue growth, driven by increasing enrollment in Medicaid, Medicare Advantage, and Marketplace plans. Profitability is expected to improve as Centene manages medical costs and achieves greater efficiency. Analysts predict annual revenue growth of 5-8% over the next 3-5 years.

Recent Initiatives: Recent strategic initiatives include acquisitions to expand its presence in new markets, investments in technology to improve care management, and efforts to reduce administrative costs.

Summary

Centene is a significant player in the managed care industry, particularly within government-sponsored healthcare programs. Its strengths lie in its Medicaid expertise and large scale. While facing challenges such as regulatory risks and margin pressures, Centene is positioned for continued growth through market expansion and strategic initiatives. Investors must watch how it handles its large debt and focus on expansion beyond Medicaid.

Similar Stocks

Sources and Disclaimers

Data Sources:

  • Company Filings (SEC)
  • Industry Reports
  • Analyst Estimates
  • Company Website

Disclaimers:

The data and analysis provided are for informational purposes only and should not be considered financial advice. Market data and analyst estimates are subject to change.

Upturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Centene Corp

Exchange NYSE
Headquaters Saint Louis, MO, United States
IPO Launch date 2001-12-13
CEO & Director Ms. Sarah M. London
Sector Healthcare
Industry Healthcare Plans
Full time employees 60500
Full time employees 60500

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, and commercial organizations in the United States. The company operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans. This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, federal, and corporate management services. It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers. The company was founded in 1984 and is headquartered in Saint Louis, Missouri.